I am deeply concerned that the article entitled, “Immunex takes premature step to guarantee Enbrel market share,” which appeared in the February issue of Nature Biotechnology, contained serious ...

In November 2000, Immunex (Seattle, WA) initiated a patient enrollment program designed to increase year-end sales of its anti-inflammatory drug Enbrel. Immunex claims the program was implemented ...

A Colorado board voted unanimously Feb. 16 to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible showdown ...